Wednesday, December 7, 2011

Updates from San Antonio

We will provide updates every evening of the 2011 San Antonio Breast Cancer Symposium.
Tonight's review:

2011 SAN ANTONIO BREAST CANCER SYMPOSIUM NEWS ROUNDUP

December 7, 2011

Today's abstracts reaffirm the benefits of using Zometa with endocrine therapy to prevent recurrence. There is now a test for recurrence risk in DCIS patients. The poor prognosis of overweight women is further studied. And, directly in line with our Before Forty Initiative, Hispanic women are diagnosed younger than non-hispanics and are more likely to develop a very aggressive, non-responsive form of Triple Negative Breast Cancer. They have a high mortality rate. Imagine if our Before Forty Initiative was able to help these women? We are working hard to do just that. Abstracts below. More to follow tomorrow.


Please go HERE for full report

No comments: